We observed that TCRP1 was overexpressed in most of human cancer, including lung cancer, glioma, ovarian cancer, thyroid cancer, nasopharyngeal carcinoma, pancreatic cancer, stomach cancer and tongue carcinoma, which suggested a possible role of TCRP1 in tumor development and progression. Here, FAM168A is linked to ovarian carcinoma.